Removing things from your life that no longer serve you is a sure sign that you are experiencing a Dark Night of the Soul.

Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion ...

How can school leaders make sure that teachers are motivated and engaged throughout their careers? The first step might be better understanding the different phases—and associated needs—of teachers’ ...

While orbiting Earth, the moon undergoes a series of phases, each marked by its unique appearance in the sky The moon has captivated humanity since the beginning of time, but what deeper significance ...

First patient dosed in the Phase 1 trial of IMC-P115C, marking a significant milestone in the development of Immunocore's novel immunotherapy. IMC-P115C is designed to improve patient convenience by ...

SELLAS Life Sciences is developing GPS as a WT1 immunotherapy, which is in Phase 3 for AML. However, I believe their SLS009 candidate as a CDK9 inhibitor further gives the stock broad AML ...

ANAVEX3-71-SZ-001 achieved its primary endpoint demonstrating safety and tolerability in adults with schizophrenia Encouraging trends observed in biomarkers support continued development NEW YORK, Oct ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has granted approval to ...

STARKVILLE, Miss.—Mississippi State mechanical engineering faculty, staff and students are receiving a new space for research and collaboration with the ongoing construction of the Innovation, Design ...